FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
SPOTLIGHT: "Catching Up with Califf"
FDA’s Dietary Supplements Program Remains a Critical Priority
ODSP will remain a distinct office executing the agency’s responsibilities under the Federal Food, Drug, and Cosmetic Act for dietary supplement products.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
![Catching Up with Califf Main Image includes photo of Dr. Califf](https://public4.pagefreezer.com:443/content/FDA/18-08-2023T10:34/https://www.fda.gov/files/styles/medium_3/public/CUwC_FINAL.png?itok=1dXZ-xBq)
FDA’s Dietary Supplements Program Remains a Critical Priority
ODSP will remain a distinct office executing the agency’s responsibilities under the Federal Food, Drug, and Cosmetic Act for dietary supplement products.
![Vector image depicting a laptop and mobile phone on a desk, with several white circles housing a diverse group of employees.](https://public4.pagefreezer.com:443/content/FDA/18-08-2023T10:34/https://www.fda.gov/files/styles/medium_3/public/Radiological%20Health%20Post-Pandemic%20Stat_1600x900-01.png?itok=4QRDMdFK)
Emerging From the Pandemic: CDRH In-Person Meeting Status and Premarket Workload
CDRH is pleased to announce that we're operating under normal review timelines for incoming premarket submissions and accepting all submission types for review.
Some table information
Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
---|